a2 Milk Company Revises Outlook Due to Supply Chain Disruptions, Shares Drop 15%

Deep News
04/14

Supply chain challenges are beginning to impact earnings guidance, with The A2 Milk Co Ltd. (ACOPY) adjusting its forecasts as disruptions affect its operations in China. The company has lowered its revenue and profit outlook, citing shipment delays partly linked to Middle East conflicts that have reduced product availability for distributors and retail outlets. Management described the issue as temporary but noted that supply gaps for infant formula with Chinese labels are already affecting market availability, just as the company was poised to continue gaining market share.

Multiple points in the supply chain appear to be under strain. Air freight availability and costs have been indirectly affected by tensions in the Middle East, while sea freight capacity remains uneven. At the same time, upstream production is tightening, with unfinished purchase orders accumulating at the Synlait Milk processing facility, and additional inspection measures prolonging product release and customs clearance times. Management indicated that these factors could substantially impact product supply in April and May, potentially dragging on sales. They also expect to incur one-time logistics costs and see some cash receipts delayed until the 2026–27 fiscal year due to postponed fourth-quarter sales.

Investors reacted swiftly, sending the company’s shares down 15% in Wellington trading, marking the largest single-day decline since August 2024. The updated guidance projects revenue growth for the fiscal year ending June 2026 in the low to mid-double-digit range, down from a prior expectation of mid-double-digit growth. Operating profit margins are also expected to decline, with net profit likely to remain flat compared to the previous year rather than improve. This revision is particularly notable given earlier market expectations that A2 Milk could capture additional market share following product recalls affecting competitors, including issues identified at Nestlé. If these supply constraints persist, discussions may resurface about the need to establish production closer to China to support more stable growth.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10